Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2017
Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control studyAndrew I T Hebbard, Monica A Slavin, Caroline Reed, et al.
The Lancet. Infectious Diseases|August 14, 2025
Innovation in active and passive immunisation of people who are immunocompromised: a call to actionJoshua A Hill, Jim Boonyaratanakornkit, Malgorzata Mikulska, et al.
Internal Medicine Journal|August 27, 2021
Cytomegalovirus DNAemia and disease: current-era epidemiology, clinical characteristics and outcomes in cancer patients other than allogeneic haemopoietic transplantationKim H Tay, Monica A Slavin, Karin A Thursky, et al.
Eclinicalmedicine|August 18, 2025
Management of <i>Clostridioides difficile</i> infection in patients with haematological malignancies and after cellular therapy: guidelines from 10th European Conference on Infections in Leukaemia (ECIL-10)Malgorzata Mikulska, Christine Robin, Dionysios Neofytos, et al.
Blood Advances|July 19, 2023
Infections following bispecific antibodies in myeloma: a systematic review and meta-analysisGemma Reynolds, Edward R Scheffer Cliff, Ghulam Rehman Mohyuddin, et al.
Blood Reviews|May 9, 2026
Clostridioides difficile infection in non-transplanted adults with haematological malignancy: Systematic review and meta-analysis on behalf of European Conference on Infections in Leukemia (ECIL) and Infectious Diseases Working Party (IDWP) of the European Society for Blood and Marrow Transplantation (EBMT)Chiara Oltolini, Agnieszka Piekarska, Alessio Signori, et al.
Internal Medicine Journal|January 11, 2026
Consensus guidelines for antibacterial prophylaxis in patients with neutropeniaJulian Lindsay, Daniel Yeoh, Benjamin W Teh, et al.
Clinical & Translational Immunology|August 6, 2025
Elucidating novel immune profiles for predicting infection in high-risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemiaLewis J Williams, Connie Sn Li-Wai-Suen, Alex L Garnham, et al.
Open Forum Infectious Diseases|October 23, 2023
High Rates of Seroprotection and Seroconversion to Vaccine-Preventable Infections in the Early Post-Autologous Stem Cell Transplant PeriodVictoria G Hall, Natalie R Saunders, Emily Klimevski, et al.
Transplantation and Cellular Therapy|May 11, 2026
Infections in the first 30-days after CAR-T therapy in Patients Not Receiving Fluoroquinolone ProphylaxisGemma K Reynolds, Mark R Dowling, Jose Valencia-Klug, et al.
Pageof 7